JEOL Ltd.
6951・Prime Market・Electric Appliances
Scientific & Metrology Instruments
JEOL's core business. A global business deploying electron microscopes and analytical instruments worldwide.
| Period | Current | Previous | Change |
|---|---|---|---|
| Revenue | ¥116,295 million | ¥124,793 million | ↓ |
| Segment Profit (Operating Profit) | ¥13,069 million | ¥15,017 million | ↓ |
| Operating Profit Margin | 11.2% | 12.0% | ↓ |
| Segment Assets | ¥122,827 million | ¥109,551 million | ↑ |
| Depreciation | ¥3,333 million | ¥3,012 million | ↑ |
| Increase in Property, Plant and Equipment and Intangible Assets | ¥15,493 million | ¥3,750 million | ↑ |
Business Details
Comprising three categories: electron optics instruments (transmission electron microscopes, electron probe microanalyzers, etc.), analytical instruments (nuclear magnetic resonance devices, mass spectrometers, etc.), and metrology/inspection instruments (scanning electron microscopes, focused ion beam processing/observation systems, etc.). Main customers include universities, research institutions, semiconductor manufacturers, and next-generation battery manufacturers, making this the largest segment, accounting for approximately 65% of the group's total revenue of ¥179,353 million. The business operates globally through a network of domestic and overseas sales subsidiaries.
Recent Overview
While revenue declined 6.8% year-on-year due to the impact of U.S. science and technology budget cuts, demand centered on electron microscopes remained solid.
Revenue for FY2026 (ending March 2026) was ¥116,295 million (down 6.8% year-on-year), and segment profit was ¥13,069 million (down 12.9% year-on-year). Although there is uncertainty about the outlook due to science and technology budget cuts by the U.S. government, demand centered on electron microscopes remained solid. By region, sales to China declined significantly from ¥44,785 million in the prior period to ¥35,609 million, while sales to Japan were roughly flat. Capital expenditure expanded significantly, with the increase in tangible and intangible fixed assets reaching ¥15,493 million (versus ¥3,750 million in the prior period), reflecting aggressive capacity expansion investment.
Key Products
Growth Drivers
- Continued solid demand centered on electron microscopes (for universities, research institutions, and semiconductor manufacturers)
- Continued demand related to semiconductor manufacturing processes and next-generation battery R&D
- Continued strategic growth investment in the semiconductor and life science fields under the new medium-term management plan "Evolving Growth 2.0 -A New Horizon-" (FY2025-FY2029)
- Strengthening of the technology and product foundation related to NMR through the consolidation of Japan Superconductor Technology Inc. as a subsidiary
- Strengthening of the field-specific solution provision foundation and enhancement of added value through the "YOKOGUSHI 2.0" strategy
- Expansion of production and development capacity through large-scale capital investment (increase in fixed assets of ¥15,493 million in the current period)
Risks
- Continued uncertainty due to reductions in U.S. government science and technology-related budgets
- Significant decline in sales to China (from ¥44,785 million in the prior period to ¥35,609 million in the current period) and demand impact from China's economic stagnation and localization policy
- Uncertainty in the global economy due to geopolitical risks (prolonged situations in Ukraine and the Middle East)
- Foreign exchange risk (impact of yen appreciation on the yen-converted value of overseas sales)
- Risk of rising export costs and curtailed customer capital expenditure due to fluctuations in U.S. tariff policy
Last updated: June 23, 2026